Hysteroscopy may be the method of choice for management of residual trophoblastic tissue

被引:109
作者
Cohen, SB [1 ]
Kalter-Ferber, A
Weisz, BS
Zalel, Y
Seidman, DS
Mashiach, S
Lidor, AL
Zolti, M
Goldenberg, M
机构
[1] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Hashomer, Israel
来源
JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS | 2001年 / 8卷 / 02期
关键词
D O I
10.1016/S1074-3804(05)60577-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study Objective. To assess the efficacy of and reproductive outcome after selective curettage of residual trophoblastic tissue directed by hysteroscopy compared with conventional, nonselective, blind curettage. Design. Retrospective analysis (Canadian Task Force classification II-1). Setting. Tertiary care medical center. Patients. Seventy patients after curettage or delivery, with clinical and ultrasonographic signs of suspected residual trophoblastic tissue. Measurements and Main Results. Twenty-four women underwent traditional curettage and 46 underwent hysteroscopic selective curettage. Five (20.8%) patients who underwent traditional curettage later required operative hysteroscopy clue to persistent residual tissue. None of those who underwent hysteroscopic selective curettage needed a second operation. No patient in either group experienced anesthetic complications, perforation of the uterus, fluid overload, or other surgical complication. Reproductive outcome was similar in both groups, with tendency to conceive earlier in the hysteroscopy group, but no difference in overall pregnancy rates. Conclusion. Operative hysteroscopy for selective curettage of residual trophoblastic tissue should be considered an alternative to nonselective, blind curettage.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 4 条
  • [1] ACHIRON R, 1993, OBSTET GYNECOL, V81, P507
  • [2] CUNNINGHAM FG, 1997, WILLIAMS OBSTET, P547
  • [3] Goldenberg M, 1997, J REPROD MED, V42, P26
  • [4] Grimes David A., 1997, P477